Tower Research Capital LLC (TRC) - SCPHARMACEUTICALS INC ownership

SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 39 filers reported holding SCPHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of SCPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$85,368
+1088.3%
11,990
+1600.7%
0.00%
Q2 2023$7,184
+4564.9%
705
-95.8%
0.00%
-100.0%
Q1 2023$154
+48.1%
16,982
+17.5%
0.01%
+25.0%
Q4 2022$104
-99.8%
14,449
+80.3%
0.00%
+300.0%
Q3 2022$52,000
+67.7%
8,016
+23.4%
0.00%0.0%
Q2 2022$31,000
+3000.0%
6,496
+6396.0%
0.00%
Q1 2022$1,000
-92.3%
100
-95.3%
0.00%
Q2 2021$13,000
-27.8%
2,112
-22.7%
0.00%
Q1 2021$18,000
-5.3%
2,733
-22.8%
0.00%
-100.0%
Q4 2020$19,000
-53.7%
3,540
-36.3%
0.00%
Q3 2020$41,000
-50.6%
5,555
-50.6%
0.00%
-100.0%
Q2 2020$83,000
+591.7%
11,240
+602.1%
0.00%
+200.0%
Q1 2020$12,000
+200.0%
1,601
+151.3%
0.00%
Q4 2019$4,000
-60.0%
637
-80.2%
0.00%
-100.0%
Q2 2019$10,000
-54.5%
3,211
-56.9%
0.00%0.0%
Q1 2019$22,000
+450.0%
7,446
+625.7%
0.00%
Q4 2018$4,000
+100.0%
1,026
+273.1%
0.00%
Q3 2018$2,000
-75.0%
275
-80.8%
0.00%
Q2 2018$8,0001,4300.00%
Other shareholders
SCPHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 3,561,474$17,166,0004.25%
AIGH Capital Management LLC 1,346,724$6,491,0001.71%
Worth Venture Partners, LLC 335,985$1,784,0001.05%
Ikarian Capital, LLC 884,008$4,261,0000.78%
Orbimed Advisors 4,797,148$23,122,0000.42%
ARMISTICE CAPITAL, LLC 2,700,000$13,014,0000.23%
Sandy Cove Advisors, LLC 10,592$51,0000.05%
Belvedere Trading LLC 239,219$1,270,0000.04%
IPG Investment Advisors LLC 14,300$69,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 132,200$637,0000.02%
View complete list of SCPHARMACEUTICALS INC shareholders